INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 159 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $77,964,000 | +34.4% | 696,976 | +21.1% | 1.96% | +5.4% |
Q4 2018 | $58,027,000 | -15.9% | 575,719 | +5.5% | 1.86% | +1.9% |
Q3 2018 | $68,957,000 | +50.6% | 545,719 | 0.0% | 1.82% | +38.0% |
Q2 2018 | $45,791,000 | +36.4% | 545,719 | 0.0% | 1.32% | +42.5% |
Q1 2018 | $33,573,000 | +18.3% | 545,719 | +12.4% | 0.93% | +16.1% |
Q4 2017 | $28,376,000 | +0.7% | 485,719 | 0.0% | 0.80% | +2.4% |
Q3 2017 | $28,191,000 | -8.9% | 485,719 | +89.9% | 0.78% | -17.5% |
Q2 2017 | $30,960,000 | +7.0% | 255,719 | 0.0% | 0.95% | 0.0% |
Q1 2017 | $28,922,000 | +4.1% | 255,719 | 0.0% | 0.95% | -8.1% |
Q4 2016 | $27,784,000 | -34.0% | 255,719 | 0.0% | 1.03% | -30.5% |
Q3 2016 | $42,089,000 | +15.4% | 255,719 | 0.0% | 1.48% | +2.8% |
Q2 2016 | $36,486,000 | +11.1% | 255,719 | 0.0% | 1.44% | +10.3% |
Q1 2016 | $32,852,000 | -14.0% | 255,719 | 0.0% | 1.31% | +21.4% |
Q4 2015 | $38,192,000 | +9.3% | 255,719 | +21.4% | 1.08% | -2.9% |
Q3 2015 | $34,950,000 | -19.9% | 210,719 | +16.6% | 1.11% | -6.3% |
Q2 2015 | $43,622,000 | -0.2% | 180,719 | +16.6% | 1.18% | -9.1% |
Q1 2015 | $43,713,000 | – | 155,000 | – | 1.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |